InsiderClue
Insiders · Profile

Manning Paul B

Director at Liquidia · Director at Candel Therapeutics · Director at Verrica Pharmaceuticals · and 2 more. Filing since 19 Jun 2018. CIK 0001494695

LQDA Liquidia Corp Director · 8 trades CADL Candel Therapeutics, Inc. Director · 4 trades VRCA Verrica Pharmaceuticals Inc. Director · 26 trades TSHA Taysha Gene Therapies, Inc. 10% owner · 12 trades ABOS Acumen Pharmaceuticals, Inc. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
LQDA Liquidia Corp
4 Jun 2026
Director
Sold at will
200,000
$12.78M
21.8%
CADL Candel Therapeutics, Inc.
23 Feb 2026
Director
Bought
550,458
$3.00M
24.9%
VRCA Verrica Pharmaceuticals Inc.
25 Nov 2025
Director
Bought
2,750,762
$11.67M
460%
VRCA Verrica Pharmaceuticals Inc.
25 Nov 2025
Director
Bought
1,375,380
$5.84M
53.3%
LQDA Liquidia Corp
2 Sep 2025
Director
Sold at will
328,268
$9.45M
43.2%
LQDA Liquidia Corp
29 Aug 2025
Director
Sold at will
188,232
$5.20M
19.9%
LQDA Liquidia Corp
28 Aug 2025
Director
Sold at will
154,337
$4.31M
14.0%
TSHA Taysha Gene Therapies, Inc.
30 May 2025
10% owner
Bought
750,000
$2.06M
35.9%
CADL Candel Therapeutics, Inc.
16 Dec 2024
Director
Bought
1,250,000
$7.50M
×23
VRCA Verrica Pharmaceuticals Inc.
22 Nov 2024
Director
Bought
4,494,382
no price
303%
VRCA Verrica Pharmaceuticals Inc.
22 Nov 2024
Director
Bought
18,426,966
no price
235%
LQDA Liquidia Corp
12 Sep 2024
Director
Bought
337,078
$3.00M
70.3%
TSHA Taysha Gene Therapies, Inc.
27 Jun 2024
10% owner
Bought
1,333,333
$3.00M
opened
LQDA Liquidia Corp
14 Dec 2023
Director
Bought
279,330
$2.00M
opened
TSHA Taysha Gene Therapies, Inc.
17 Nov 2023
10% owner
Bought
100,000
$163.00K
0.6%
TSHA Taysha Gene Therapies, Inc.
16 Aug 2023
10% owner
Bought
16,466,667
$14.82M
opened
VRCA Verrica Pharmaceuticals Inc.
24 Jul 2023
Director
Bought
200,000
$1.00M
2.6%
TSHA Taysha Gene Therapies, Inc.
31 Oct 2022
Director
Bought
1,500,000
$3.00M
×11
VRCA Verrica Pharmaceuticals Inc.
5 Jul 2022
Director
Bought
4,761,904
$10.00M
53.6%
LQDA Liquidia Corp
18 Apr 2022
Director
Bought
392,156
$2.00M
opened
TSHA Taysha Gene Therapies, Inc.
3 Feb 2022
Director
Bought
50,000
$392.00K
54.2%
TSHA Taysha Gene Therapies, Inc.
3 Feb 2022
Director
Bought
26,602
$208.56K
1.3%
TSHA Taysha Gene Therapies, Inc.
2 Feb 2022
Director
Bought
67,000
$520.59K
3.4%
TSHA Taysha Gene Therapies, Inc.
2 Feb 2022
Director
Bought
58,000
$450.66K
170%
VRCA Verrica Pharmaceuticals Inc.
3 Dec 2021
Director
Bought
19,977
$184.19K
0.2%
VRCA Verrica Pharmaceuticals Inc.
2 Dec 2021
Director
Bought
30,023
$283.72K
0.4%
TSHA Taysha Gene Therapies, Inc.
24 Nov 2021
Director
Bought
2,202
$29.04K
6.9%
TSHA Taysha Gene Therapies, Inc.
23 Nov 2021
Director
Bought
20,000
$250.80K
167%
CADL Candel Therapeutics, Inc.
29 Jul 2021
Director
Bought
20,000
$145.94K
55.6%
CADL Candel Therapeutics, Inc.
27 Jul 2021
Director
Bought
36,000
$264.83K
opened
ABOS Acumen Pharmaceuticals, Inc.
6 Jul 2021
10% owner
Bought
312,500
$5.00M
10.3%
TSHA Taysha Gene Therapies, Inc.
14 May 2021
Director
Bought
12,000
$251.76K
opened
LQDA Liquidia Corp
13 Apr 2021
Director
Bought
198,413
$500.00K
36.8%
VRCA Verrica Pharmaceuticals Inc.
25 Mar 2021
Director
Bought
739,830
$10.91M
opened
VRCA Verrica Pharmaceuticals Inc.
20 Aug 2020
Director
Bought
20,000
$181.80K
0.2%
VRCA Verrica Pharmaceuticals Inc.
18 Aug 2020
Director
Bought
10,000
$85.50K
0.7%
VRCA Verrica Pharmaceuticals Inc.
17 Aug 2020
Director
Bought
6,000
$41.52K
0.4%
VRCA Verrica Pharmaceuticals Inc.
14 Aug 2020
Director
Bought
50,000
$325.50K
3.5%
VRCA Verrica Pharmaceuticals Inc.
13 Aug 2020
Director
Bought
108,500
$695.49K
8.3%
VRCA Verrica Pharmaceuticals Inc.
10 Oct 2019
Director
Bought
6,900
$103.85K
0.1%
VRCA Verrica Pharmaceuticals Inc.
9 Oct 2019
Director
Bought
8,778
$123.42K
0.1%
VRCA Verrica Pharmaceuticals Inc.
8 Oct 2019
Director
Bought
5,208
$73.02K
0.1%
VRCA Verrica Pharmaceuticals Inc.
7 Jan 2019
Director
Bought
35,625
$398.11K
0.4%
VRCA Verrica Pharmaceuticals Inc.
7 Jan 2019
Director
Bought
11,875
$132.70K
0.9%
VRCA Verrica Pharmaceuticals Inc.
13 Nov 2018
Director
Bought
20,000
$289.78K
1.6%
VRCA Verrica Pharmaceuticals Inc.
13 Nov 2018
Director
Bought
20,000
$289.78K
0.2%
VRCA Verrica Pharmaceuticals Inc.
12 Nov 2018
Director
Bought
15,100
$206.73K
1.2%
VRCA Verrica Pharmaceuticals Inc.
12 Nov 2018
Director
Bought
15,100
$206.73K
0.2%
VRCA Verrica Pharmaceuticals Inc.
10 Aug 2018
Director
Bought
33,000
$497.64K
0.4%
VRCA Verrica Pharmaceuticals Inc.
19 Jun 2018
Director
Bought
200,000
$3.00M
2.6%
VRCA Verrica Pharmaceuticals Inc.
19 Jun 2018
Director
Bought
100,000
$1.50M
8.6%
51 decisions on file.